The shares of the biopharmaceutical company gained up to 8 percent after the company’s subsidiary got approval from Japan’s health authority for an immunity drug.  With a market capitalization of Rs 45,910.94 crore, the shares of Biocon Ltd were trading at Rs 382.05 per share, increasing around 7 percent as compared to the previous closing … Continue reading Pharma stock jumps 8% after it gets approval from Japan’s health authority for immunity drug